Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Non-Tech : Kirk's Market Thoughts -- Ignore unavailable to you. Want to Upgrade?

To: Winfastorlose who wrote (8673)	3/26/2020 10:06:01 AM
From: Clam digger	Read Replies (2) \| Respond to of 26450

Are these any new stories? They look like same ones I’ve seen for several days now? Btw don’t get me wrong I do believe there may be something significant in the treatment of Covid 19 with plaquenil and z-pak but would love to see some new data.... Also interesting info is out there on how all the testing, reporting etc has led to current situation.

To: Winfastorlose who wrote (8673)	3/26/2020 11:14:20 AM
From: Kirk ©	1 Recommendation Recommended By Winfastorlose Respond to of 26450

Yup, loads of good news and reasons for optimism. I believe Generic Hydroxycholoquine has been limited to patients who need it for rheumatoid arthritis and is very difficult to get... so the patients who really need it can have it until Bayer and others can ramp up the supply. By the time the supply is ready, hopefully the science to back FDA approval to use it prophylactically is also ready and they can send us pills via the mail. Realistically, they probably delay sending us pills in the mail until they have reams of data, but they can hopefully open up the economy when they have solid data showing this is a good treatment and our death rate stops dead just as the death rate in China from the virus did.